The forecast for malignant neoplasms of the colon, rectum, and anus mortality among females in the UK suggests a steady decline from 2024 to 2028. Starting with a standardized rate of 17.7 deaths per 100,000 women in 2024, the rate is expected to decrease incrementally each year, reaching 16.5 by 2028. Given that the rate in 2023 was 18.0, the trend indicates a year-on-year decline of about 1.7% to 1.8% annually. Observing this over a five-year period results in an average compound annual growth rate (CAGR) of roughly -1.7%.
Future trends to watch for include advancements in early detection and treatment options, which can further reduce mortality rates, and public health initiatives aimed at prevention through lifestyle changes. Monitoring technological and pharmaceutical developments will be critical in continuing this downward trend.
